Oncolys BioPharma Inc.JP:4588Balance sheet

Market cap
¥37.9B
P/E ratio
2013/122014/122015/122016/122017/122018/122019/122020/122021/122022/122023/122024/12
Cash and cash equivalents -4,7273,6052,5642,8682,4633,3432,0683,4551,7111,5332,411
Total current assets-4,8853,6742,7473,0722,6183,8262,5464,1982,6091,9563,098
Property, plant and equipment, net-5946-321221----
Marketable securities, non-current -252483524006683290----
Total non-current assets-124332394455812554251944285101
Total assets -5,0094,0063,1403,5263,4304,3802,7964,2922,6512,0413,199
Short-term debt-17393639383128150239228128128
Total current liabilities-263177205239212524415430322379252
Long-term debt, non-current -337303300344311389367256156161167
Total non-current liabilities-374328318355317402378268170188194
Total liabilities -637504523594529926793698492567447
Common stock and paid-in capital -10,13710,13710,17411,59712,79814,24514,89718,1033,5864,8337,803
Retained earnings--5,781-6,638-7,569-8,660-9,894-10,806-12,901-14,517-1,435-3,373-5,058
Stockholders' equity5,0944,3713,5012,6172,9322,9013,4542,0033,5942,1591,4742,752